Jun 17, 2020
United Therapeutics Announces Increase Data Presentation at an American Thoracic Society Virtual Session
May 26, 2020
Insmed to Present at Two June Conferences
Apr 30, 2020
Insmed Reports First Quarter 2020 Financial Results and Provides Business Update
Apr 29, 2020
United Therapeutics Corporation Reports First Quarter 2020 Financial Results
Apr 23, 2020
United Therapeutics Announces Additional Results From FREEDOM-EV Study Showing The Hemodynamic And Risk Status Reduction Benefits Of Orenitram Treatment In Patients With Pulmonary Arterial Hypertension
Apr 03, 2020
Results from Expert Delphi Consensus Survey on Treatment of Pulmonary Arterial Hypertension (PAH) with Oral Prostacyclin Pathway Agents (PPAs) Published in CHEST Journal
Apr 03, 2020
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Mar 05, 2020
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Feb 24, 2020
United Therapeutics Announces INCREASE Study Of Tyvaso® Meets Primary And All Secondary Endpoints
Feb 24, 2020
United Therapeutics and DEKA Announce Additional FDA Clearance Related to the Unity Subcutaneous Delivery System for Remodulin®
Feb 19, 2020
Insmed to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Feb 05, 2020
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jan 03, 2020
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Dec 11, 2019
Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder Value
Nov 05, 2019
Insmed to Present at Two November Conferences
Nov 04, 2019
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Oct 21, 2019
United Therapeutics Announces FDA Approval Of Updated Label For Orenitram Reflecting Results Of FREEDOM-EV Study
Oct 18, 2019
Persistent Pulmonary Hypertension of the Newborn Pipeline Insights 2019 Featuring United Therapeutics, Mallinckrodt, Proteo Biotech, Beyond Air, Farmacon-IL, Merck Sharp & Dohme
Oct 07, 2019
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Sep 12, 2019
Correvio Highlights FDA Acceptance of United Therapeutics' Trevyent New Drug Application